The Washington State Employment Security Department said in the filing that 72 employees will be laid off on Jan. 17. A ...
More cuts are hitting Gilead’s cell therapy wing, including the closure of a Philadelphia office. A small number of additional job reductions are also being made across the broader company, according ...
In less than six months, the county’s around-the-clock Mobile Crisis Response Team has helped 81 individuals in an efficient ...
Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...
Data shows Latino and Black people make up nearly 30% of the Bay Area population but only about 10% of active medical ...
Watch video of Massillon football's Mateo Herrera kicking a 36-yard field goal against McKinley as time expired in the first half News Sports Entertainment Lifestyle Opinion Advertise Obituaries ...
Please verify your email address. Despite its age, Grand Theft Auto: San Andreas had one immersive feature that Rockstar games have since omitted, and GTA 6 should change that. They may seem ...
STAT+ subscribers can sign up here to get it delivered to their inbox. The next referendum on Gilead Sciences’ oft-criticized oncology business is approaching. Circle Nov. 5 on your calendars.
Gilead Sciences, Inc. (GILD), headquartered in Foster City, California, is a global biopharmaceutical leader known for its groundbreaking work in antiviral therapies. Valued at a market cap of $ ...
Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Gilead Sciences (GILD – Research Report) and keeping the price target at $84.00. Terence Flynn’s rating is based on ...
A 31-year-old San Mateo woman who police say robbed a man she met on Facebook was arrested Friday on suspicion of kidnapping and robbery, police said. The woman had arranged to meet the victim for ...
The treatment combines MSD’s islatravir with Gilead’s lenacapavir. Credit: Ground Picture via Shutterstock. Gilead Sciences and MSD are advancing their once-weekly HIV treatment regimen to Phase II ...